# Hanerxi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hanerxi

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Total disclosed funding: $1.6M
- Latest round: Series A (Jul 27, 2024)
- Investors on record: 4

## About

Established in 2014 and based in Suzhou, China, Hanerxi is a medical device company focus on the research and development of pen-type syringes. In 2018, the company developed a cartridge-type injection pen. In 2020, it developed a fully automatic injection pen. In August 2024, the firm closed a series A+ funding.

The company main business is research, development, production and sales of pen-type syringes. The company products use in the autonomous treatment of chronic diseases such as insulin and growth hormone, precision medicine such as interferon, various cells, genes, biological agents, and cosmetic needles used in consumer medical scenarios.

## Funding rounds

- Series A, Jul 27, 2024 — CCB International, Fuzhe Capital, Lishui Fuchu Fund
- Series A, Dec 15, 2021, $1.6M — NSR Wealth Management

## Investors

- NSR Wealth Management (https://capitalatlas.ai/funds/nsr-wealth-management) — Series A
- CCB International (https://capitalatlas.ai/funds/ccb-international) — Series A
- Fuzhe Capital (https://capitalatlas.ai/funds/fuzhe-capital) — Series A
- Lishui Fuchu Fund — Series A